add share buttonsSoftshare button powered by web designing, website development company in India

There has been a dramatic rise in news attention to medicinal cannabis in 2013, with reports on CNN, ABC, CBS, and local publications about high-cannabidiol cannabis oil effectively controlling the symptoms of rare epileptic conditions like Dravet syndrome, Doose syndrome, infantile spasms, cortical dysplasia, and more.

These diseases can cause hundreds to thousands of seizures a week, while also impairing development in a number of other ways. For families with children suffering from such conditions, the challenges are overwhelming.

Due to the extremely complex nature of Dravet and related syndromes, traditional pharmaceuticals are ineffective and often make the problems worse. With no other hope, families have turned to high-CBD cannabis concentrates which is proving to work with miraculous efficacy.

To clarify, high-CBD cannabis oil is non-psychoactive and apparently even more beneficial than high-THC cannabis oil. Cannabidiol is another cannabinoid in the cannabis plant, like the more well-known psychoactive cannabinoid THC, with significant research suggesting neuroprotectant, anticancer, antidiabetic, anti-ischemic, antispasmodic, antipsychotic, and antibacterial properties, among others.

Furthermore, cannabis oil is a type of extract from cannabis. Such oil contains large amounts of concentrated cannabinoids that can be orally ingested rather than smoked, preserving the medicinal compounds and allowing them to be delivered through digestive system, rather than the respiratory system.

The research suggests that CBD has panacea-like properties, and in practice, this is proving to be the case. On August 11th, 2013, Sanjay Gupta released a documentary on CNN about Charlotte Figi. Charlotte is a young Dravet syndrome patient who was having 300 grand mal seizures a week.

The Use of High-Cannabidiol Cannabis in Canada
Tagged on: